WHO Register of non-State actors

Disclaimer:

Information regarding a non-State actor, contained in the section “Non-State Actors Profiles” in the Register, has been provided by that non-State actor itself, and the accuracy and completeness of such information is the sole responsibility of that non-State actor, not WHO. In turn, information in the sections “WHO’s Engagement” and “Non-State Actors in Official Relations” has been provided by WHO, subject to certain conditions. All access and use of any section of the Register is governed by the Terms and Conditions of Use.

Overview

Official name

ASSITEB-BIORIF- Association Internationale des Technologistes Biomédicaux

Acronym (if applicable)

ASSITEB-BIORIF

Short self description

ASSITEB-BIORIF coordinates a network of professionals in 24 countries. The association is a partner by its presence especially in Central and West Africa and Madagascar and by its missions of valorization of the laboratories role and the reinforcement of their capacities particulary by improving all the stages of the quality and safety, equipement, installations, maintenance and especially training and staff qualification.

Website

www.assiteb-biorif.org

Web link to health relevant activities

Parent entity (if applicable)

The entity you represent is indicated as a parent of the following entities in the Register:

N / A

Date submitted

03 Sep 2024 04:52:15 PM

General information

Name

Official name

ASSITEB-BIORIF- Association Internationale des Technologistes Biomédicaux

Acronym (if applicable)

ASSITEB-BIORIF

Commonly used name (if applicable)

ASSITEB-BIORIF

Names in other official languages (if applicable) Name Abbreviation

ASSITEB-BIORIF

Former name

Short self description

Address

Address 1

33 rue de METZ

Address 2

Address 3

Town/City

LE PERREUX sur MARNE

State/Region

Postal code

94170

Country

France

Related links

Website

www.assiteb-biorif.org

Governance

Legal status

association

Year established

1982

Governance structure

Description of main decision making bodies (e.g. board, board of directors, executive board, executive committee, etc).

Name of body

Board of directors conseil d'administration

Composition and current list of members Name Function Affiliation

FABIN Claire

President

Doctor Private hospital sector

DAOUD Daniel Karim

Vice-President

Paris Area Veterinary Laboratory Director

JOFFIN Jean-Noel

Treasurer

Public High School Teacher

JOFFIN Christiane

General Secretary

Public High School Teacher

BERTRU Nicole

Administrator

Public High School Teacher (retired)

BIMET François

Administrator

Biologist Engineer (Institut Pasteur Paris)

FATINDE Alain

Administrator

Reference Laboratory for Mycobacteria Cotonou

RICHARD Jean-Jacques

Administrator

Private Laboratory Director Paris (retired)

BEJAOUI Skander

General Secretary Assistant

Biologist Enginner(Reproductive Biology) Tunis)

TEMBELY Saïdou

Administrator

Public High School Teacher veterinarian biologist Bamakoy o

Functions

Members elected by the General Assembly for 3 years :
- deliberating on the orientations and the activities,
- daily managing
- stopping the annual accounts.

Name of body

Office

Composition and current list of members Name Function Affiliation

FABIN Claire

President

Doctor Private hospital sector

DAOUD Daniel Karim

Vice-President

Paris Area Veterinary Laboratory Director

JOFFIN Christiane

General Secretary

Public High School Teacher

BEJAOUI Skander

General Secretary Assistant

Biologist Enginner(Reproductive Biology) Tunis)

JOFFIN Jean-Noel

Treasurer

Public High School Teacher

Functions

The office
- convenes and manages the board of directors and the General Assembly
- manages and administers the Association .

General Assembly

Does the entity have a General Assembly of members or a similar body?

Yes

Name

General Assembly

Composition

All members of the association

Functions

Role of decision, validation and control
-Meeting once a year
- Report sent to members
- Vote by members up to date with contributions
in accordance with the statutes

Financial information

Latest available annual income (month/year)

From

October

2022

September

2023

Annual income (USD)

22,580

Latest available assets (month/year)

As of

September

2023

Total assets (USD)

5,030

Income sources (in USD)

Income source Income type

Private sector entities (including business associations)

Philanthropic foundations

NGOs, academic institutions

Government entities, intergovernmental organizations, including UN

General public, individuals

Total

Sales of goods and services *

500

Grants / Donations

17,550

In-kind donations

4,000

Membership fees

530

Investment income

Others

Total

5,030

17,550

22,580

* income from congresses / conferences should be listed under Sales of goods and services

Additional information

Sale of goods: new edition booklets "Prevention of biological risk in the laboratory" and "Prevention of chemical risk in the laboratory"
Donations in kind: 10 revised microscopes and in good condition
Subsidies: WHO 10,000 USD + OMSA 4000 USD + OIF3550 USD

Membership

Entity's members

Is the entity you represent membership based?

Yes

Overview of categories and their voting rights in the main governing body:

Total number Voting

Individuals

NGOs

Private sector entities

Philanthropic foundations

Academic institutions

Government entities

Intergovernmental organizations

Organizational Structure

Parent entity

In the register Registered Entity Entity Name

No data available

Yes

Legal status

Affiliated entities (or subsidiaries)

In the register Registered Entity Entity Name

No data available

Yes

DGLFLF :General Delegation about french language and languages in France

Yes

ILO : International Labour Organization (OIT : Organisation internationale du travail)

Yes

OIF : International Organization Francophonie (Organisation Internationale Francophone

Yes

OMSA : World Organization for Animal Health

Yes

RAPF: Réseau des associations professionnelles francophones

Relations

Entity's membership in other entities

In the register Registered Entity Entity Name Type of membership

No data available

Yes

CRTL (RDC) : Association of laboratory technicians

Partnership with

Yes

GERES (France) : study group on the risk of exposure of caregivers to infectious agents

Partnership with

Yes

LRSFS : regional laboratory of wild life

Partnership with

Yes

PCD : Pathology Cytology Developpment

Partnership with

Yes

UATI : Internationale Union of scientific and Technical Associations and Organisations (UNESCO)

Partnership with

Yes

UPBM (France) : Association of Professors of physiology biochemical microbiology

Partnership with

Members of the entity

In the register Registered Entity Member Name

No data available

Yes

Individual active members and national professional associations

Activities

Aims (or purposes, objectives) of the entity as they appear in its constitution or by-laws or equivalent document.

Capacity building of technicians

The activities of the entity are related to the following strategic priorities and outcomes of the current WHO's General Programme of Work:

Strategic objective 1: Respond to climate change, an escalating health threat in the 21st century

Joint outcome 1.1. More climate-resilient health systems are addressing health risks and impacts

Joint outcome 1.2. Lower-carbon health systems and societies are contributing to health and well-being

Strategic objective 2: Address health determinants and the root causes of ill health in key policies across sectors

Joint outcome 2.1. Health inequities reduced by acting on social, economic, environmental and other determinants of health

Joint outcome 2.2. Priority risk factors for noncommunicable and communicable diseases, violence and injury, and poor nutrition, reduced through multisectoral approaches

Joint outcome 2.3. Populations empowered to control their health through health promotion programmes and community involvement in decision-making

Strategic objective 3: Advance the primary health care approach and essential health system capacities for universal health coverage

Joint outcome 3.1. The primary health care approach renewed and strengthened to accelerate universal health coverage

Joint outcome 3.2. Health and care workforce, health financing and access to quality-assured health products substantially improved

Joint outcome 3.3. Health information systems strengthened and digital transformation implemented.

Strategic objective 4: Improve health service coverage and financial protection to address inequity and gender inequalities

Joint outcome 4.1. Equity in access to quality services improved for noncommunicable diseases, mental health conditions and communicable diseases, while addressing antimicrobial resistance

Joint outcome 4.2. Equity in access to sexual, reproductive, maternal, newborn, child, adolescent and older person health and nutrition services and immunization coverage improved

Joint outcome 4.3. Financial protection improved by reducing financial barriers and out-of-pocket health expenditures, especially for the most vulnerable

Strategic objective 5: Prevent, mitigate and prepare for risks to health from all hazards

Joint outcome 5.1. Risks of health emergencies from all hazards reduced and impact mitigated

Joint outcome 5.2. Preparedness, readiness and resilience for health emergencies enhanced

Strategic objective 6: Rapidly detect and sustain an effective response to all health emergencies

Joint outcome 6.1. Detection of and response to acute public health threats is rapid and effective

Joint outcome 6.2. Access to essential health services during emergencies is sustained and equitable

Additional information on the entity's activities

ASSITEB-BIORIF is member of PNMCH and of 'Every Women, Every Child'.
ASSITEB-BIORIF works on violence against women and the management of biochemical waste
ASSITEB-BIORIF works about "infertility and Laboratory".
ASSITEB-BIORIF works about hygiene in laboratories and hospitals and about AMR.

Country presence

Countries where the entity has activities, members and regional offices / representatives:

Regions

Countries

Activities

Members

Offices / representatives

African Region

Region of the Americas

Eastern Mediterranean Region

European Region

South-East Asia Region

Western Pacific Region

Global

Disclosure & declaration

Tobacco/Arms related disclosure statement for non-State actors

Pursuant the WHO Framework of Engagement with Non-State Actors, WHO does not engage with the tobacco industry or non-State actors that work to further the interests of the tobacco industry. WHO also does not engage with the arms industry.

For the purposes of this statement:

tobacco industry means any entity involved in the manufacture, sale or distribution of tobacco and related products, and any affiliate of such entity; and
arms industry means any entity involved in the manufacture, sale or distribution of arms, and any affiliate of such entity.

This disclosure statement needs to be provided by any nongovernmental organization, private sector entity, philanthropic foundation and academic institution prior to engaging with WHO.

In view of the foregoing, please answer the following questions:

Is your entity, or was your entity over the last four years, part of the tobacco or arms industries (as defined above)?

Yes

No

Unable to answer

To the best of your entity’s knowledge, is your entity, or has your entity over the last four years, engaged in activities that are aimed at furthering or supporting the interests of the tobacco industry? This includes, but is not limited to, supply contracts, contract work, services and lobbying.

Yes

No

Unable to answer

To the best of your entity’s knowledge, does your entity currently, or did your entity over the last four years, have any other association or relationship with the tobacco industry (as defined above). This includes in particular investment interests (other than general mutual funds or similar arrangements whereby your entity has no control over the selection of the investments), commercial business interests, the provision or receipt of financial and/or other support.

Yes

No

Unable to answer

If you have answered yes to any of the above or are unable to answer one or more questions, please provide a general statement of explanation.

Please note that the WHO Secretariat reserves the right to request additional information from your entity in this regard.

By providing this statement, your entity commits to promptly inform WHO of any change to the above information and to complete a new statement that describes the changes.

Engagement with other industries affecting human health or affected by WHO norm and standards

Does the entity you represent have any formal association, affiliation or links with the following industry sectors?

If yes, please tick the box of the industry concerned and provide details in the space provided:

Alcohol

Chemical

Food and beverages

Health care

Pharmaceutical

Others

Please specify industry

WHO Secretariat reserves the right to request additional information from the entity you represent relevant to its engagement with WHO.

*Sexual Exploitation, Abuse and Harassment (SEAH) and Misconduct (abusive or fraudulent)

Entities engaging with WHO are expected to ensure that the conduct of their employees and any other persons engaged by them to perform any activities or to provide any services for WHO on behalf of the entities is consistent with the WHO standards of conduct. In particular, WHO has zero tolerance towards any form of sexual misconduct, which includes sexual exploitation, sexual abuse, sexual violence, and sexual harassment, and other types of abusive or fraudulent conduct. In the view of the forgoing, please confirm that your entity shall:

Take all reasonable and appropriate measures to prevent sexual misconduct as defined in WHO’s Policy on Preventing and Addressing Sexual Misconduct, and other types of abusive or fraudulent conduct as defined, respectively, in WHO’s Policy on Preventing and Addressing Abusive Conduct and in WHO’s Policy on Prevention, Detection and Response to Fraud and Corruption by any of its employees and by any other persons engaged by it to perform any activities or to provide any services for WHO on the entity’s behalf;

Promptly report to WHO’s Office of Internal Oversight Services (IOS) at investigation@who.int any actual or suspected misconduct, as defined by WHO in these Policies and of which the entity becomes aware;

Promptly communicate to IOS any measures that may be necessary or appropriate to protect the confidentiality and wellbeing of the alleged victim;

Promptly respond to any actual or suspected misconduct as defined by WHO in these Policies of which the entity becomes aware; and

To cooperate with IOS and keep IOS informed of the status and outcome of any measures of protection, corrections to operations, investigation, and disciplinary action taken against any perpetrator by the entity.

Date submitted